Back to stocks
NSRX
Nasus Pharma Ltd.• Healthcare
Institutional holders
9
As of Q3 2026
Total 13F value
$7.8M
Sum of disclosed positions
New positions
1
This quarter
Sold positions
2
This quarter
Top holders
Institutions with disclosed positions in this stock
| Fund | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
Balyasny Asset Management L.P. | $3.3M | 898.5K | 0.00% | Unchanged |
Cable Car Capital, Lp | $2.3M | 616.1K | 0.26% | Unchanged |
Velan Capital Investment Management Lp | $1.3M | 359.4K | 1.27% | Unchanged |
Hudson Bay Capital Management Lp | $497K | 134.8K | 0.00% | Unchanged |
Bleichroeder Lp | $332K | 89.8K | 0.03% | Unchanged |
Renaissance Technologies | $54K | 14.6K | 0.00% | +19.7% |
Pinnacle Financial Group, Inc. | $36K | 9.7K | 0.00% | New Position |
Morgan Stanley | $4K | 1.0K | 0.00% | Unchanged |
Caitong International Asset Management Co., Ltd | $15 | 4 | 0.00% | Unchanged |